A new report from the Lancet Global Commission calls for a shift in how obesity is diagnosed, moving beyond the traditional Body Mass Index (BMI).

Refined carbs are carbohydrates that have gone through extensive processing that strips them of certain nutrients, such as ...

A panel of health experts looking at obesity announced that the definition of the condition should be split into two ...

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.

Stock prices for Novo Nordisk fell by about 3% at market open after the Biden administration selected its revolutionary drugs ...

Diabetes and weight loss drugs Ozempic and Wegovy have been added to the list of medications selected for Medicare price ...

BMI is a 53-year-old metric that experts suggest needs an update—here's what they say is the more reliable way to determine ...

Ozempic was one of the 15 drugs selected for the 2027 Medicare drug price negotiation program three days before ...